Alphabet Inc., the parent company of Google, finds itself at a confluence of strategic expansion and legal scrutiny this week. While a major new partnership signals deep inroads into a key industry, a recent court ruling in Canada adds to its regulatory challenges. These developments unfold as the company’s shares trade notably below their February peak and a dividend payment approaches.
Dividend and Investment Surge Highlight Financial Health
Investors are set to receive a dividend of $0.21 per share on March 9. This comes on the heels of a strong fourth-quarter 2025 performance, where Alphabet reported earnings per share of $2.82, surpassing the analyst consensus estimate of $2.63. Revenue for the period climbed to $113.83 billion.
A striking announcement accompanied these results: Alphabet’s capital expenditure for 2026 is projected to be between $175 billion and $185 billion, focusing on infrastructure. The upper end of this range represents more than double the 2025 investment. This aggressive spending is largely directed toward supporting artificial intelligence capabilities, a sector showing robust adoption with nearly 75% of Google Cloud customers now using the company’s AI products. The market will be watching closely when next quarterly results are published on April 23, 2026, for signs that this massive investment is yielding returns.
Strategic AI Partnership with CVS Health
A significant driver of future growth is Alphabet’s push into lucrative vertical markets through Google Cloud. On March 5, 2026, a strategic alliance with CVS Health was unveiled. The collaboration centers on CVS’s new technology subsidiary, Health100, which is developing an integrated consumer health platform. This platform is designed to work across any pharmacy, insurer, or digital health service a patient uses.
Should investors sell immediately? Or is it worth buying Alphabet?
Leveraging AI agents and Google’s Gemini models, the initiative aims to provide users with a real-time health partner. A launch is scheduled for 2026, with further details expected at Google’s health event, “The Check Up,” in March. This deal underscores Google Cloud’s successful expansion beyond pure technology clients. The division’s revenue surged 48% year-over-year in Q4 2025 to $17.7 billion, propelled by demand for its AI infrastructure and enterprise solutions.
Mounting Regulatory Pressure in Canada
On the regulatory front, Alphabet faced a setback on March 4 in Canada. The country’s Competition Tribunal rejected Google’s attempt to dismiss an ongoing antitrust case on constitutional grounds. Canada’s Competition Bureau had initially filed the lawsuit in November 2024, accusing Google of abusing its dominant position in the digital advertising market.
According to the Bureau’s estimates, Google commands approximately a 90% share of the publisher ad server market in Canada, alongside 70% of the ad network market and roughly 50% of the ad exchange market. The regulatory body is seeking a court order for the divestiture of two of Google’s advertising services and the imposition of a financial penalty. This case joins a growing list of antitrust and regulatory confrontations Alphabet is managing across multiple jurisdictions globally.
Ad
Alphabet Stock: Buy or Sell?! New Alphabet Analysis from March 7 delivers the answer:
The latest Alphabet figures speak for themselves: Urgent action needed for Alphabet investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 7.
Alphabet: Buy or sell? Read more here...









